p53‐independent Noxa induction by cisplatin is regulated by ATF3/ATF4 in head and neck squamous cell carcinoma cells

The platinum‐based DNA damaging agent cisplatin is used as a standard therapy for locally advanced head and neck squamous cell carcinoma (HNSCC). However, the mechanisms underpinning the cytotoxic effects of this compound are not entirely elucidated. Cisplatin produces anticancer effects primarily v...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Kanika, Vu, Thien‐Trang, Cook, Wade, Naseri, Mitra, Zhan, Kevin, Nakajima, Wataru, Harada, Hisashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983129/
https://www.ncbi.nlm.nih.gov/pubmed/29352505
http://dx.doi.org/10.1002/1878-0261.12172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983129/
https://www.ncbi.nlm.nih.gov/pubmed/29352505
http://dx.doi.org/10.1002/1878-0261.12172

Ejemplares similares